Related Experiment Video
Updated: May 7, 2026
10:46
Sampling Cerebrospinal Fluid and Blood from Lateral Tail Vein in Rats During EEG Recordings
Published on: September 1, 2023
Epilepsy in Cambodia-treatment aspects and policy implications: a population-based representative survey
Devender Bhalla1, Kimly Chea, Chamroeun Hun
1Institut National de la Santé et de la Recherche Médicale UMR 1094, Tropical Neuroepidemiology, Limoges, France ; Univ. Limoges, School of Medicine, Institute of Neuroepidemiology and Tropical Neurology, Centre national de la recherche scientifique FR 3503 GEIST, Limoges, France ; Centre Hospitalier Universitaire, Limoges, France ; Cambodian Society of Neurology, Phnom Penh, Cambodia.
Plos One
|September 17, 2013
Summary
Conventional epilepsy treatment with phenobarbital or valproate effectively reduced seizures and complications. This study confirms accessible treatments can significantly lessen the epilepsy burden.
Area of Science:
- Neurology
- Public Health
- Pharmacology
Background:
- Epilepsy management strategies require evaluation for prognosis, safety, adherence, and policy implications.
- Assessing treatment effectiveness and resource needs is crucial for scaling up epilepsy care.
Purpose of the Study:
- To compare two epilepsy treatment delivery strategies: patient door-step delivery versus health center-based care.
- To evaluate treatment prognosis, safety, adherence, patient satisfaction, productivity, and policy aspects.
Main Methods:
- A random-cluster survey identified 96 epilepsy cases in 24 villages for a comparative treatment study.
- Patients received cost-free phenobarbital or valproate with minimal dosage and no polytherapy.
- Treatment delivery occurred via patient door-steps (primary-treatment-period) and health centers (treatment-continuation-period).
Main Results:
- Seizure frequency decreased from 12.6 to 1.2 during the primary treatment period, with a later increase to 3.4.
- >60% of patients remained seizure-free between the start and end of treatment.
- Complications decreased from 12.5% to 4.2% during the primary treatment period, while adverse events reduced from 46.8% to 16.6%.
Conclusions:
- Conventional epilepsy treatments are effective even with minimal dosage and simple regimens.
- Accessible treatments can substantially reduce the direct burden of epilepsy.
- The study highlights the feasibility of improving epilepsy care with existing resources.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...